HKEX filing shows BlackRock reduced its H-share stake in Jiangsu Hengrui Medicine from 7.15% to 6.96% on Sept 24, selling at an average price of HK$47.481.

2026-09-29

HKEX filing shows BlackRock reduced its H-share stake in Jiangsu Hengrui Medicine from 7.15% to 6.96% on Sept 24, selling at an average price of HK$47.481.